26.73
前日終値:
$26.86
開ける:
$26.72
24時間の取引高:
553.15K
Relative Volume:
0.68
時価総額:
$2.20B
収益:
$1.93B
当期純損益:
$174.22M
株価収益率:
13.03
EPS:
2.0516
ネットキャッシュフロー:
$237.32M
1週間 パフォーマンス:
+3.48%
1か月 パフォーマンス:
+8.26%
6か月 パフォーマンス:
+27.29%
1年 パフォーマンス:
+110.97%
Pediatrix Medical Group Inc Stock (MD) Company Profile
名前
Pediatrix Medical Group Inc
セクター
電話
(954) 384-0175
住所
1301 CONCORD TERRACE, SUNRISE, FL
Compare MD vs HCA, THC, DVA, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
MD
Pediatrix Medical Group Inc
|
26.73 | 2.15B | 1.93B | 174.22M | 237.32M | 2.0516 |
|
HCA
Hca Healthcare Inc
|
408.18 | 86.43B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
257.62 | 20.96B | 21.46B | 2.65B | 3.35B | 19.23 |
|
DVA
Davita Inc
|
240.96 | 15.17B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.86 | 13.36B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
113.80 | 11.30B | 6.07B | 793.80M | 464.40M | 5.9914 |
Pediatrix Medical Group Inc Stock (MD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-16 | 開始されました | Macquarie | Outperform |
| 2024-09-26 | アップグレード | Jefferies | Hold → Buy |
| 2024-06-07 | アップグレード | Deutsche Bank | Sell → Hold |
| 2021-09-27 | 開始されました | SVB Leerink | Mkt Perform |
| 2021-06-23 | 再開されました | Stifel | Hold |
| 2020-10-19 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2020-01-03 | ダウングレード | Citigroup | Buy → Neutral |
| 2019-12-12 | アップグレード | Stifel | Hold → Buy |
| 2019-09-06 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2019-01-15 | アップグレード | Citigroup | Neutral → Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Hold |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-09-24 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
| 2018-09-18 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2018-08-03 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-07-12 | 開始されました | Leerink Partners | Mkt Perform |
| 2018-03-27 | 開始されました | Credit Suisse | Neutral |
| 2018-02-12 | 繰り返されました | Mizuho | Neutral |
| 2017-12-13 | 開始されました | Piper Jaffray | Overweight |
| 2017-09-18 | アップグレード | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2017-05-30 | 繰り返されました | Mizuho | Neutral |
| 2017-05-25 | 繰り返されました | Stifel | Hold |
| 2017-05-04 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2017-03-21 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2017-03-10 | ダウングレード | JP Morgan | Overweight → Neutral |
すべてを表示
Pediatrix Medical Group Inc (MD) 最新ニュース
Pediatrix Medical Group Inc (MD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MD|Pediatrix Medical Group Inc|Price:26.260| - TradingKey
Pediatrix Medical Group, Inc. Revenue Breakdown – NYSE:MD - TradingView
Pediatrix Medical Group Inc (MD) Cash Flow - TradingKey
Pediatrix Medical Group Announces General Counsel Leadership Transition - TipRanks
Pediatrix Medical Group (NYSE: MD) installs new general counsel after Moore exit - Stock Titan
Pediatrix Medical Group, Inc. Announces Executive Changes - marketscreener.com
Pediatrix Medical Group (NYSE:MD): A Decent Value Stock at a Discount - ChartMill
Pediatrix Medical Group Inc (MD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MD Forecast — Price Target — Prediction for 2027 - TradingView
Is Pediatrix Medical Group (MD) Overvalued As It Reaffirms Its 2026 EBITDA Outlook? - Yahoo Finance
MD4766160 Bond Risk Profile - TradingView
Stable Payor Mix And Reaffirmed Outlook Might Change The Case For Investing In Pediatrix (MD) - Yahoo Finance
Pediatrix Medical Group (MD) Soars 7.3%: Is Further Upside Left in the Stock? - NewsBreak: Local News & Alerts
MD5355101 Bond Risk Profile - TradingView
Pediatrix Medical Group, Inc. (MD) Stock Forecasts - Yahoo Finance
Pediatrix Medical Group (MD) Reaffirms Outlook Following Stable Payor Mix, Is The Strength Already Priced In? - simplywall.st
A Look at Pediatrix Medical Group Inc (MD) After 7.3% Gain -- GF Value $13.18 vs Price $25.88 - GuruFocus
MD5355101 Bond Profile — Key Metrics - TradingView
Pediatrix Medical Group Reiterates 2026 Adjusted EBITDA Outlook - Moomoo
Pediatrix reaffirms $280–$300 million EBITDA outlook - grafa.com
Pediatrix Medical Group Reaffirms 2026 Outlook With Stable Payor Mix and Adjusted EBITDA Guidance of $280M–$300M – Minichart - Minichart
Pediatrix Medical (MD) Maintains Stable Q2 Trends Amid Market Sh - GuruFocus
Pediatrix reaffirms FY26 outlook, confirms stable payor mix - scanx.trade
Pediatrix Medical Group (NYSE: MD) keeps 2026 EBITDA view as payor mix holds - Stock Titan
Pediatrix reaffirms 2026 outlook amid stable payor trends By Investing.com - Investing.com Canada
Pediatrix Medical Group Provides Second Quarter Update - Business Wire
Pediatrix Medical Group (NYSE: MD) 5.1% stake held via Dimensional funds - Stock Titan
Pediatrix Medical Group Drops 5.7% After Truist Securities Maintains Hold - AlphaStreet
Analysts Offer Insights on Healthcare Companies: Pediatrix Medical Group (MD) and Travere Therapeutics (TVTX) - The Globe and Mail
Why Pediatrix Medical Group (MD) is a top momentum stock for the long term - MSN
MD stock holds steady as Pediatrix business context stays in view - Ad-hoc-news.de
Pediatrix Medical Group (MD) Joins Russell Defensive Indexes, Is The Upside Already Priced In? - Sahm
Does Pediatrix (MD) Joining Russell Defensive Indexes Recast Its Profile as a Value-Safe Haven? - simplywall.st
Pediatrix Medical Group stock hits 52-week high at 25.02 USD - Investing.com South Africa
ETFs Investing in Pediatrix Medical Group, Inc. Stocks - TradingView
Pediatrix Medical Group (MD) is a top-ranked growth stock: Should you buy? - MSN
Pediatrix Medical Group, Inc.(NYSE: MD) added to Russell 2000 Value-Defensive Index - marketscreener.com
Pediatrix Medical Group, Inc.(NYSE: MD) added to Russell 2000 Defensive Index - marketscreener.com
Pediatrix Medical Group (MD) Slips 0.7% as Stock Tests Key Support LevelBollinger Band - dars.gov.et
Pediatrix Medical Group, Inc. Actuals & Estimates (NYSE:MD) - TradingView
Price to earnings forward of Pediatrix Medical Group, Inc. – NYSE:MD - TradingView
Enterprise value to EBITDA forward of Pediatrix Medical Group, Inc. – NYSE:MD - TradingView
Is Ongoing Sales Weakness and Softer Returns Reshaping the Investment Case For Pediatrix (MD)? - Sahm
Form 4 Pediatrix Medical Group Inc For: 24 June By Investing.com - Investing.com South Africa
[Form 4] Pediatrix Medical Group, Inc. Insider Trading Activity - Stock Titan
Pediatrix (MD) EVP and General Counsel David Haddock submits initial Form 3 - Stock Titan
Here's why Pediatrix Medical Group (MD) is a strong momentum stock - MSN
Pediatrix Medical Group Inc (NYSE:MD): A Decent Value Play in a Bull Market - ChartMill
Pediatrix Medical Group Inc (MD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Pediatrix Medical Group StockLong-term strategy and business model in focus - AD HOC NEWS
Pediatrix Medical Group Inc (MD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):